search
Back to results

Feasibility Study Over the NAVA Mode in Noninvasive Ventilation After Cardiac Surgery in Infants. (NIVNAVA)

Primary Purpose

Heart Defects, Congenital, Surgery

Status
Completed
Phase
Phase 4
Locations
Belgium
Study Type
Interventional
Intervention
NivNava
Cpap
Sponsored by
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Defects, Congenital focused on measuring cardio-pulmonary bypass

Eligibility Criteria

undefined - 12 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Weight ≤ 5 kg
  • Postoperative period of cardiac surgery with cardiopulmonary bypass (max 10 days after surgery)
  • Conventional ventilation
  • Agreement with the extubation criteria
  • Arterial line

Exclusion Criteria:

  • High frequency oscillation ventilation
  • Extubation criteria not fulfilled
  • Proven or suspected sepsis
  • Absence of arterial line
  • Oesophageal pathology (Excepted gastro-oesophageal reflux)

Sites / Locations

  • Cliniques Univeristaires Saint-Luc

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

NAVAfirst

Cpap first

Arm Description

Starting crossover by NIVnava mode

Start crossover by Cpap on nasal canula

Outcomes

Primary Outcome Measures

Evaluation of the percentage of asynchronies during the nava mode
One of the aims of the NAVA mode is to provide better synchronization between the child's breathing needs and the breathing cycles given by the ventilator. By comparing the EDI curve (electric activity of the diaphragm of the child) and the flow and pressure curves of the ventilator, it is possible to determine the percentage of asynchronies during the nava mode

Secondary Outcome Measures

Comparison of breathing rhythm between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode
Comparison of PEEP (positive end expiratory pressure) between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode
Comparison of Inspiratory Pressure between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode
Comparison of FiO2 between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode
Comparison of PaO2 between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode
Comparison of PaCO2 between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode
Comparison of blood pH between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode

Full Information

First Posted
March 6, 2012
Last Updated
December 6, 2013
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
search

1. Study Identification

Unique Protocol Identification Number
NCT01570933
Brief Title
Feasibility Study Over the NAVA Mode in Noninvasive Ventilation After Cardiac Surgery in Infants.
Acronym
NIVNAVA
Official Title
Feasibility Study Over the Neurally Adjusted Ventilatory Assist (NAVA) Mode in Noninvasive Ventilation After Cardiac Surgery in Infants.
Study Type
Interventional

2. Study Status

Record Verification Date
December 2013
Overall Recruitment Status
Completed
Study Start Date
November 2011 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
December 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Neonates who underwent cardiac surgery with cardiopulmonary bypass almost always require non-invasive respiratory support (NIV) in relay to conventional ventilation. Current nasal interfaces do not generally allow synchronised bilevel ventilation. NIV-NAVA mode allows, through an oesophageal catheter, to record the electrical activity of the diaphragm and thereby synchronize breaths from the ventilator on the inspiratory efforts of the child. Moreover, the pressure support delivered by the ventilator may be proportional to the diaphragmatic effort developed by the child. This mode, associated with the interface Miniflow®, could increase the comfort of the child by allowing a more efficient synchronization and reducing its respiratory work. To our knowledge, this ventilation mode with this interface has not been evaluated in the postoperative period of cardiac surgery in the newborns. The purpose of this study is to evaluate the feasibility of this ventilatory mode and evaluate its influence on ventilatory parameters of this category of infants.
Detailed Description
Study Design: Single centre prospective crossover study Study Objectives: Main objectives: Assessment of the feasibility of non invasive ventilation in NIV-NAVA mode via Miniflow® interface in infants of less than 3.5 kg after cardiac surgery with cardiopulmonary bypass. Evaluation of the following parameters: Implementation of the interface Air leaks Placement and contention of oesophageal probe Quality of synchronization Obstruction of the probe Risk of nasal wounds Secondary objectives: Comparison of ventilation parameters between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode Evaluation of the following parameters: Breathing rhythm Tidal volume PEEP Inspiratory pressure FiO2 PaO2 PaCO2 pH Evolution of EAdi min and EAdi max parameters in NIV-NAVA mode (EAdi : diaphragmatic electric activity) Conduct of the study: First phase: placement of EADI catheter and extubation When extubation criteria are met, the oesophageal EADI catheter is placed according to the manufacturer's instructions. The ventilation mode is then switched to Pressure Support Mode with the same Peep as in the previous mode and a pressure support of 10 cmH2O. During 30 minutes, trends in respiratory rate, tidal volume, PEEP, inspiratory pressure, FiO2, EADI min, EADi max are recorded. After 30 minutes, an arterial blood gas analysis is performed to determine the values of PaCO2, PaO2 and pH before randomization. The child is extubated according to the procedures of the service and the non-invasive ventilation relay is introduced through the Miniflow® interface with nasal prongs adapted to the morphology of the child. An adrenaline nebulisation can be given before starting NIV in case of respiratory distress due to laryngeal oedema. Second phase: nCPAP or NIV-NAVA Following randomisation, the child is included in the "nCPAP first" arm or "NIV-NAVA first" arm and is ventilated in the designated mode for 30 minutes. During the first 15 minutes, the ventilation parameters are adapted according to the procedures below: nCPAP parameters adaptation: PEEP and FiO2 as previously set in invasive ventilation; FiO2 according to target SpO2 values of the child and/or 10% higher than FiO2 in invasive ventilation mode; PEEP between 4-6 cmH2O in order to minimize respiratory efforts. NIV-NAVA parameters adaptation: PEEP and FiO2 as previously set in invasive ventilation; Adaptation of the NIV-NAVA level to reach a EADi level equal to the mean EADi level over the last 5 minutes of the invasive mode. Inspiratory pressure and tidal volume are limited respectively to 30 cmH2O and 8 ml/kg. FiO2 according to target SpO2 values of the child and/or 10% higher than FiO2 in invasive ventilation mode ; PEEP between 4-6 cmH2O in order to minimize respiratory efforts. Over the last 15 minutes of this ventilation mode, trends in respiratory rate, tidal volume, PEEP, inspiratory pressure, FiO2, EADI min, EADi max are recorded. On Minutes M16, M21 and M29 in NIV-NAVA mode, synchronisation data are recorded : auto-triggering, double triggering, inspiration beginning and ending. After 30 minutes, an arterial blood gas analysis is performed to determine the evolution of the values of PaCO2, PaO2 and pH. At any time, if the re-intubation criteria are met, the child is re-intubated and returned to conventional ventilation. He is then excluded of the study. Third phase: nCPAP or NIV-NAVA The ventilation mode is changed from nCPAP to NIV-NAVA or from NIV-NAVA to nCPAP. The adaptation protocol and the recorded parameters are the same as in the second phase. After 30 minutes, an arterial blood gas analysis is performed to determine the evolution of the values of PaCO2, PaO2 and pH. At any time, if the re-intubation criteria are met, the child is re-intubated and returned to conventional ventilation. He is then excluded of the study. Fourth phase: end of the study The study concludes at the end of the third phase. The child is left in the better tolerated ventilation mode, as judged by the clinician.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Defects, Congenital, Surgery
Keywords
cardio-pulmonary bypass

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
NAVAfirst
Arm Type
Experimental
Arm Description
Starting crossover by NIVnava mode
Arm Title
Cpap first
Arm Type
Active Comparator
Arm Description
Start crossover by Cpap on nasal canula
Intervention Type
Device
Intervention Name(s)
NivNava
Other Intervention Name(s)
Neurally adjusted ventilatory assist
Intervention Description
Non-invasive Nava ventilation mode on nasal cannula
Intervention Type
Device
Intervention Name(s)
Cpap
Other Intervention Name(s)
InfantFlow(R), CareFusion(R), SanDiego, Ca, USA
Intervention Description
nasal Cpap on nasal cannula
Primary Outcome Measure Information:
Title
Evaluation of the percentage of asynchronies during the nava mode
Description
One of the aims of the NAVA mode is to provide better synchronization between the child's breathing needs and the breathing cycles given by the ventilator. By comparing the EDI curve (electric activity of the diaphragm of the child) and the flow and pressure curves of the ventilator, it is possible to determine the percentage of asynchronies during the nava mode
Time Frame
from minute zero to minute 90
Secondary Outcome Measure Information:
Title
Comparison of breathing rhythm between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode
Time Frame
from minute zero to minute 90
Title
Comparison of PEEP (positive end expiratory pressure) between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode
Time Frame
from minute zero to minute 90
Title
Comparison of Inspiratory Pressure between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode
Time Frame
from minute zero to minute 90
Title
Comparison of FiO2 between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode
Time Frame
from minute zero to minute 90
Title
Comparison of PaO2 between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode
Time Frame
from minute zero to minute 90
Title
Comparison of PaCO2 between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode
Time Frame
from minute zero to minute 90
Title
Comparison of blood pH between nasal Continuous Positive Airway Pressure (nCPAP) mode and NIV-NAVA mode
Time Frame
from minute zero to minute 90

10. Eligibility

Sex
All
Maximum Age & Unit of Time
12 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Weight ≤ 5 kg Postoperative period of cardiac surgery with cardiopulmonary bypass (max 10 days after surgery) Conventional ventilation Agreement with the extubation criteria Arterial line Exclusion Criteria: High frequency oscillation ventilation Extubation criteria not fulfilled Proven or suspected sepsis Absence of arterial line Oesophageal pathology (Excepted gastro-oesophageal reflux)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laurent Houtekie, md
Organizational Affiliation
Cliniques Universitaires Saint-LUc, Brussels
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cliniques Univeristaires Saint-Luc
City
Brussels
ZIP/Postal Code
1200
Country
Belgium

12. IPD Sharing Statement

Citations:
PubMed Identifier
25691764
Citation
Houtekie L, Moerman D, Bourleau A, Reychler G, Detaille T, Derycke E, Clement de Clety S. Feasibility Study on Neurally Adjusted Ventilatory Assist in Noninvasive Ventilation After Cardiac Surgery in Infants. Respir Care. 2015 Jul;60(7):1007-14. doi: 10.4187/respcare.03624. Epub 2015 Feb 17.
Results Reference
derived

Learn more about this trial

Feasibility Study Over the NAVA Mode in Noninvasive Ventilation After Cardiac Surgery in Infants.

We'll reach out to this number within 24 hrs